C
Carlsmed, Inc.
CARL · NASDAQ · Healthcare · 389M
Closing price
$14.42
+2.63% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.1×
Enterprise value / EBITDAEV/EBITDA
-4.9×
Free cash flow yieldFCF yield
-14.4%
Return on equityROE
-30.0%
Operating margin
-60.5%
Net debt / EBITDAbalance-sheet strength
2.4×
Interest coverage
-21.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.